I listened to the interview with the CEO after the recent announcement and found it very interesting.
The key takeaway for me was the fact that PME estimate that they have approx 6% market share of the US market and there are quite a number of other software vendors such that no-one has a large chunk of it.
Given that the Visage product seems to be technically better than the rest there is massive scope for significant growth in market share and for the system to be used beyond the traditional radiology space (eg cardiology).
I am guessing that they will not be chasing the very small clinics but if they were to get to 15% market share it would make the current PE ratio look a whole lot better....
I will hold on to my remaining shares now...
I listened to the interview with the CEO after the recent...
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$112.66 |
Change
-3.350(2.89%) |
Mkt cap ! $11.76B | |||
| Open | High | Low | Value | Volume |
| $115.91 | $117.26 | $112.19 | $42.71M | 375.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 602 | $112.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $112.91 | 731 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$112.40 |
Change
-3.350 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| $116.16 | $117.23 | $112.24 | 60966 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| PME (ASX) Chart |